Literature DB >> 18662092

A reassessment of the in vitro RBC haemolysis assay with defibrinated sheep blood for the determination of the ocular irritation potential of cosmetic products: comparison with the in vivo Draize rabbit test.

Eloísa Nunes Alves1, Rosaura de Farias Presgrave, Octávio Augusto França Presgrave, Fernanda Peres Sabagh, João Carlos Borges Rolim de Freitas, Alexandre P Corrado.   

Abstract

We examined the correlation between results obtained from the in vivo Draize test for ocular irritation and in vitro results obtained from the sheep red blood cell (RBC) haemolytic assay, which assesses haemolysis and protein denaturation in erythrocytes, induced by cosmetic products. We sought to validate the haemolytic assay as a preliminary test for identifying highly-irritative products, and also to evaluate the in vitro test as alternative assay for replacement of the in vivo test. In vitro and in vivo analyses were carried out on 19 cosmetic products, in order to correlate the lesions in the ocular structures with three in vitro parameters: (i) the extent of haemolysis (H50); (ii) the protein denaturation index (DI); and (iii) the H50/DI ratio, which reflects the irritation potential (IP). There was significant correlation between maximum average scores (MAS) and the parameters determined in vitro (r = 0.752-0.764). These results indicate that the RBC assay is a useful and rapid test for use as a screening method to assess the IP of cosmetic products, and for predicting the IP value with a high level of concordance (94.7%). The assay showed high sensitivity and specificity rates of 91.6% and 100%, respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662092     DOI: 10.1177/026119290803600305

Source DB:  PubMed          Journal:  Altern Lab Anim        ISSN: 0261-1929            Impact factor:   1.303


  3 in total

1.  Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use.

Authors:  Martin J D Clift; Vicki Stone
Journal:  Theranostics       Date:  2012-07-25       Impact factor: 11.556

2.  In vitro biocompatibility of a sandblasted, acid-etched HA composite coating on ultrafine-grained titanium.

Authors:  Yanxia Chi; Sipeng An; Yunpeng Xu; Mingda Liu; Jie Zhang
Journal:  RSC Adv       Date:  2021-02-03       Impact factor: 3.361

3.  Cyclodextrin Enhances Corneal Tolerability and Reduces Ocular Toxicity Caused by Diclofenac.

Authors:  Hamdy Abdelkader; Zeinab Fathalla; Hossam Moharram; Taha F S Ali; Barbara Pierscionek
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.